Russian Sputnik V vaccine is 91.6% effective, says The Lancet medical journal

Vacuna rusa Sputnik V tiene una eficacia del 91.6%, asegura revista médica The Lancet

An interim analysis of data from the phase III trial of Russia’s covid-19 vaccine (Sputnik V) suggests that a two-dose regimen is 91.6% effective against symptomatic disease; a protection that in people over 60 is very similar and rises to 91.8%. Preliminary results, published in “The Lancet,” are based on analysis of data from nearly …

Russian Sputnik V vaccine is 91.6% effective, says The Lancet medical journal Read More »